530 related articles for article (PubMed ID: 17564905)
1. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
Gómez-Martínez LE
Int J Toxicol; 2007; 26(3):237-46. PubMed ID: 17564905
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of D,L-3-hydroxy-3-ethyl-3-phenylpropionamide (HEPP) in pregnant rats at different stages of gestation and maternal-fetal disposition during late pregnancy.
Fletes Mdel R; Gómez-Martínez LE
Reprod Toxicol; 2003; 17(2):177-84. PubMed ID: 12642150
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of HEPP, a new anticonvulsant, in healthy subjects and rabbits after multiple doses.
González-Esquivel DF; Pérez RM; Cook HJ
Biopharm Drug Dispos; 2004 Mar; 25(2):85-90. PubMed ID: 14872556
[TBL] [Abstract][Full Text] [Related]
4. Reproductive safety studies with genistein in rats.
McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
[TBL] [Abstract][Full Text] [Related]
5. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
Tzimas G; Thiel R; Chahoud I; Nau H
Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
[TBL] [Abstract][Full Text] [Related]
6. Diphenyl ditelluride effect on embryo/fetal development in mice: interspecies differences.
Roman SS; Nava A; Favero AM; Weis SN; Zeni G; Rocha JB; Nogueira CW
Toxicology; 2007 Mar; 231(2-3):243-9. PubMed ID: 17196317
[TBL] [Abstract][Full Text] [Related]
7. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
8. Effects of tert-butyl acetate on maternal toxicity and embryo-fetal development in Sprague-Dawley rats.
Yang YS; Ahn TH; Lee JC; Moon CJ; Kim SH; Park SC; Chung YH; Kim HY; Kim JC
Birth Defects Res B Dev Reprod Toxicol; 2007 Oct; 80(5):374-82. PubMed ID: 17948321
[TBL] [Abstract][Full Text] [Related]
9. Embryo-fetal development toxicity of prenatal exposure to penequine hydrochloride intramuscularly in rats.
Zhang Z; Zhang Q; Wang Z; Wei J; Wang A
Food Chem Toxicol; 2007 Apr; 45(4):592-9. PubMed ID: 17134811
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the toxic and teratogenic potential of the anticonvulsant drug 4-hydroxy, 4-ethyl, 4-phenylbutyramide in mice.
Chamorro G; Salazar M; Salazar S; Ulloa V; Carvajal G; Martínez D
Arch Med Res; 1994; 25(4):441-6. PubMed ID: 7858404
[TBL] [Abstract][Full Text] [Related]
11. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits.
García AL; Medina RL; Pérez MR; Jung CH
Biopharm Drug Dispos; 2003 Jul; 24(5):205-9. PubMed ID: 12784320
[TBL] [Abstract][Full Text] [Related]
12. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
13. Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring.
Chung MK; Kim CY; Kim JC
Cancer Chemother Pharmacol; 2007 Feb; 59(3):383-95. PubMed ID: 16896929
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats.
Danielsson B; Sköld AC; Azarbayjani F; Ohman I; Webster W
Toxicol Appl Pharmacol; 2000 Mar; 163(2):164-75. PubMed ID: 10698674
[TBL] [Abstract][Full Text] [Related]
15. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development.
Burdan F; Szumilo J; Klepacz R
Reprod Toxicol; 2009 Sep; 28(2):239-44. PubMed ID: 19379806
[TBL] [Abstract][Full Text] [Related]
16. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
17. Developmental toxicity of thiodiglycol in Sprague-Dawley rats.
Houpt JT; Crouse LC; Angerhofer RA; Leach GJ; Reddy G
Int J Toxicol; 2007; 26(4):365-71. PubMed ID: 17661228
[TBL] [Abstract][Full Text] [Related]
18. The role of maternal toxicity in lovastatin-induced developmental toxicity.
Lankas GR; Cukierski MA; Wise LD
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
[TBL] [Abstract][Full Text] [Related]
19. Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the rat.
Miranda ES; Miekeley N; De-Carvalho RR; Paumgartten FJ
Reprod Toxicol; 2006 Apr; 21(3):292-300. PubMed ID: 16271447
[TBL] [Abstract][Full Text] [Related]
20. Repeated administration of diphenyl diselenide to pregnant rats induces adverse effects on embryonic/fetal development.
Weis SN; Favero AM; Stangherlin EC; Manarin FG; Rocha JB; Nogueira CW; Zeni G
Reprod Toxicol; 2007 Feb; 23(2):175-81. PubMed ID: 17095185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
